ONCAlert | Upfront Therapy for mRCC
Latest From
FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer
11:53 AM, Mon March 30, 2020
FDA Approves Durvalumab for Extensive-Stage Small Cell Lung Cancer
11:53 AM, Mon March 30, 2020
Expert Expands on Evolving Treatment Strategies for Prostate and Urothelial Cancers
12:00 PM, Sun March 29, 2020
.jpg "Immunotherapy Induces Responses in Subtypes of Sarcomas")
Immunotherapy Induces Responses in Subtypes of Sarcomas
2:00 PM, Sat March 28, 2020
Immunotherapy Induces Responses in Subtypes of Sarcomas
2:00 PM, Sat March 28, 2020
Sequential Genomic Testing Could Reveal Efficacy, Patterns of Resistance in Metastatic CRC
12:00 PM, Sat March 28, 2020
Trending News on Targeted Oncology, Week of March 27, 2020
11:09 PM, Fri March 27, 2020
Daratumumab Added to Standard of Care Improves Survival in Multiple Myeloma
10:00 PM, Fri March 27, 2020
Wakelee Discusses Osimertinib in EGFR-Mutated NSCLC
9:00 PM, Fri March 27, 2020
Updated Response Data for Melflufen Combination Calls for NDA in Multiple Myeloma
7:50 PM, Fri March 27, 2020
